. (A) Alignment of E-protein AD1 domains from different species. The evolutionarily conserved PCET (p300/CBP and ETO target) sequence mediates interactions with both ETO family corepressors and p300/CBP and GCN5 coactivators. Also highlighted are the three Eprotein member-specific amino acids that are conserved in HEB and E2-2, but are different in E2A.
and E2A using anti-FLAG antibody. (B) GST pull-down assays comparing the interactions of fulllength ETO with full-length E2A and E2A derivatives. Replacing the AD1 of E2A with HEB-AD1, or mutating amino acids M24P27L28 to ASP, strongly enhanced the ETO interaction with E2A. The right panel shows quantification of the relative binding of the indicated E2A derivatives to GST-ETO. (C) Luciferase assays showing that replacing the AD1 domain of E2A with HEB-AD1 restored the strong ETO-mediated repression and the high-affinity binding to the ETO corepressor. Thus, the chimeric protein containing the AD1 domain of HEB and the AD2 domain of E2A (HEB-AD1-E2A-AD2) showed reduced transcriptional activity and increased sensitivity to ETO-mediated repression compared to E2A-AD1-E2A-AD2, which contains the AD1 and AD2 domains of E2A. To allow direct comparison of E2A-AD1 and HEB-AD1, both proteins lack the DES domain. Western blot analysis showed comparable expression of both proteins ( Supplementary Fig. 6D ). showing that expression of E2ADES, but not E2A, reduced AML1-ETO occupancy while enhancing GCN5 occupancy on the RASSF2 enhancer. ChIP assays were performed in Kasumi-1 cells transduced with empty vector, FLAG-tagged E2A, or FLAG-tagged E2ADES, using anti-FLAG (C), anti-ETO (D) and anti-GCN5 (E) antibodies. ChIP enrichment was determined as % of input. P values were calculated from two-tailed t-test. "*": P < 0.05. "**": P < 0.01. with E2A or E2ADES in HEK293T cells was immunoprecipitated with anti-FLAG M2-agarose followed by Western blot analysis of the indicated proteins. E2A and E2ADES were detected using anti-E2A antibody, and FLAG-ETO-2 was detected using anti-FLAG antibody. Figure S12 . Comparison of our HEB-PCET-TAFH model and the structure of the HEB-PCET-KIX complex (2kwf). Shown are stereo view of superimposed HEB-PCET-TAFH structure (from this study) and the structure of the HEB-PCET-KIX complex with PCET conformation closest to that in the HEB-PCET-TAFH model. Both structures were loaded into the workspace of the UCSF Chimera program (version 1.7) and superimposed based on their PCET conformation. S28, D19, and D22 were specifically involved in intermolecular interactions with TAFH residues including K98E and R151, but not with KIX, explaining the specific requirement of S28, D19, and D22 residues for repression but not activation. 
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